The DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
Loss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis
Open accessAbstract
Microglia and macrophages accumulate at the sites of active demyelination and neurodegeneration in the multiple sclerosis brain and are thought to play a central role in the disease process. We used recently described markers to characterize the origin and functional states of microglia/macrophages in acute, relapsing and progressive multiple sclerosis. We found microglia activation in normal white matter of controls and that the degree of activation increased with age. This microglia activation was more pronounced in the normal-appearing white matter of patients in comparison to controls and increased with disease duration. In contrast to controls, the normal-appearing white matter of patients with multiple sclerosis showed a significant reduction of P2RY12, a marker expressed in homeostatic microglia in rodents, which was completely lost in active and slowly expanding lesions. Early stages of demyelination and neurodegeneration in active lesions contained microglia with a pro-inflammatory phenotype, which expressed molecules involved in phagocytosis, oxidative injury, antigen presentation and T cell co-stimulation. In later stages, the microglia and macrophages in active lesions changed to a phenotype that was intermediate between pro- and anti-inflammatory activation. In inactive lesions, the density of microglia/macrophages was significantly reduced and microglia in part converted to a P2RY12+ phenotype. Analysis of TMEM119, which is expressed on microglia but not on recruited macrophages, demonstrated that on average 45% of the macrophage-like cells in active lesions were derived from the resident microglia pool. Our study demonstrates the loss of the homeostatic microglial signature in active multiple sclerosis with restoration associated with disease inactivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Similarly, microglia in active MS lesions lack Tmem119 (Satoh et al., 2016; Zrzavy et al., 2017).”
From Activated microglia drive demyelination via CSF1R signaling (2021) · cites this paper as Zrzavy et al., 2017
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microglial cells within active white matter lesions are characterized by the absence of homeostatic markers such as P2RY12 and an upregulation of CXCR4, indicating a shift to a disease-associated state (31, 41, 42).”
From The role of microglia in multiple sclerosis: implications for treatment with Bruton’s tyrosine kinase inhibitors (2025) · cites this paper as [41]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TMEM119 is one of the main homeostatic microglia markers that is not expressed on monocyte-derived macrophages and has been shown to be downregulated in active MS lesions and other inflammatory conditions of the brain47–49.”
From CHIT1 at diagnosis predicts faster disability progression and reflects early microglial activation in multiple sclerosis (2024) · cites this paper as [47]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, the phenotype of microglia we observed in HDLS is similar to that found in an SOD1 ALS mouse model and in multiple sclerosis patients, in which the molecules associated with the homeostatic microglial phenotype (e.g., P2RY12, CSF-1R) are down-regulated and inflammatory markers are up-regulated [24, 57].”
From Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy (2020) · cites this paper as [57]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As reported previously (Zrzavy et al., 2017), P2RY12+ cells expressing TSPO were substantially reduced in active lesions (Fig. 2E–H).”
From A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis (2019) · cites this paper as Zrzavy et al., 2017
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, in contrast to the pattern of TSPO expression in rodent models, it may not be so specifically associated with pro-inflammatory microglia in multiple sclerosis (Zrzavy et al., 2017).”
From A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis (2019) · cites this paper as Zrzavy et al., 2017
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Indeed, most phagocytes initially present in active MS lesions are microglia, and with lesion maturation, more macrophages will infiltrate from the blood47.”
From CHIT1 at diagnosis predicts faster disability progression and reflects early microglial activation in multiple sclerosis (2024) · cites this paper as [47]
The cited source says what the claim attributes to it.
In the citing paper
“TMEM119 is one of the main homeostatic microglia markers that is not expressed on monocyte-derived macrophages and has been shown to be downregulated in active MS lesions and other inflammatory conditions of the brain47–49.”
From CHIT1 at diagnosis predicts faster disability progression and reflects early microglial activation in multiple sclerosis (2024) · cites this paper as [47]
In the citing paper
“The loss of homeostatic microglial proteins is visible in immunofluorescence double-staining of IBA1 and TMEM119 in terminally sick mice and mock-infected healthy control brains, and shows the reciprocal regulation of both proteins in prion disease (Figure 5A) [55,73,88,89,90,91].”
From Loss of Homeostatic Microglia Signature in Prion Diseases (2022) · cites this paper as [90]
In the citing paper
“since its expression is maintained by resident human microglia in MS lesions and is not expressed by infiltrating immune cells (Zrzavy et al., 2017).”
From Complex cell-state changes revealed by single cell RNA sequencing of 76,149 microglia throughout the mouse lifespan and in the injured brain (2018) · cites this paper as Zrzavy et al., 2017
In the citing paper
“Several of these microglial genes were also observed in human microglia, including P2RY12 and TMEM119 (REFs25,33–36).”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [36]
In the citing paper
“In human MS, microglia lose the expression of the P2RY12 homeostatic microglial marker and adopt a pro-inflammatory phenotype that includes the expression of phagocytic-related markers (macrosialin (also known as CD68)), antigen presentation markers (MHC class I and II molecules and T lymphocyte activation antigen CD86) and proteins involved in the production of reactive oxygen species (cytochrome”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [36]
In the citing paper
“and appears to exhibit stable expression even in response to a variety of inflammatory conditions (9, 96).”
From The Transcriptional Landscape of Microglial Genes in Aging and Neurodegenerative Disease (2019) · cites this paper as [96]
In the citing paper
“Studies have shown that microglial migration, proliferation, and activation are involved in the onset and progression of disease in acute, relapsing, and progressive forms of MS in humans (Zrzavy et al. 2017).”
From MiR-124 and MiR-155 as Therapeutic Targets in Microglia-Mediated Inflammation in Multiple Sclerosis (2025) · cites this paper as Zrzavy et al. 2017
In the citing paper
“However, activation conditions are variable and microglial phenotype changes with disease progression (Zrzavy et al. 2017).”
From MiR-124 and MiR-155 as Therapeutic Targets in Microglia-Mediated Inflammation in Multiple Sclerosis (2025) · cites this paper as Zrzavy et al. 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Self-citationthe Immunological Genome Consortium, Gautier, E. L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., Helft, J., Chow, A., Elpek, K. G., et al. (2012) · Nature Immunology · doi:10.1038/ni.2419 · Cited by 1,972 · cited 1×
“…to be microglia-specific in comparison to other brain cells (Chiu et al., 2013; Hickman et al., 2013) or in comparison to peripheral myeloid cells (Gautier et al., 2012; Hickman et al., 2013; Butovsky et al., 2014) or to be involved in pro- or anti-inflammatory microglia/macrophage function such…”
BackgroundNew tools for studying microglia in the mouse and human CNS
Bennett, M. L., Bennett, F. C., Liddelow, S. A., Ajami, B., Zamanian, J. L., Fernhoff, N. B., Mulinyawe, S. B., Bohlen, C. J., Adil, A., Tucker, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525528113 · Cited by 1,804
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777 · cited 1×
“It has been suggested to stimulate remyelination (Butovsky et al., 2006; Miron et al., 2013) and early stages of remyelination within multiple sclerosis lesions are mainly seen in the core of active lesions (Raine et al., 1981; Prineas et al., 1993; Raine, 2017).”
A polarizing question: do M1 and M2 microglia exist?
Ransohoff, R. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4338 · Cited by 1,573
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
Flagged first, then by citations
1 of the 68 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Babinski, 1885, Recherches sur l’anatomie pathologique de la sclerose en plaque et étude comparative des diverses variétés de la scleroses de la moelle, Arch Physiol, 5, 186
- Marburg, 1906, Die sogenannte akute multiple Sklerose, J Psychiatric Neurol, 27, 1
Cited by
Sorted by citations
Items 101–200 of 698
Augusto‐Oliveira, M., Arrifano, G. D. P., Delage, C. I., Tremblay, M., Lopez, M. E. C., & Verkhratsky, A. (2021) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12797 · Cited by 114
Bar, E., & Barak, B. (2019) · Glia · doi:10.1002/glia.23637 · Cited by 108
Role of dietary fatty acids in microglial polarization in Alzheimer’s disease
Desale, S. E., & Chinnathambi, S. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01742-3 · Cited by 112
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis
Calabrese, M., Preziosa, P., Scalfari, A., Colato, E., Marastoni, D., Absinta, M., Battaglini, M., Stefano, N. D., Filippo, M. D., Hametner, S., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26913 · Cited by 115
Self-citationDominant role of microglial and macrophage innate immune responses in human ischemic infarcts
Zrzavy, T., Machado‐Santos, J., Christine, S., Baumgartner, C., Weiner, H. L., Butovsky, O., & Lassmann, H. (2018) · Brain Pathology · doi:10.1111/bpa.12583 · Cited by 118
Self-citationMolecular signature of slowly expanding lesions in progressive multiple sclerosis
Jäckle, K., Zeis, T., Schaeren‐Wiemers, N., Junker, A., van der Meer, F., Kramann, N., Stadelmann, C., & Brück, W. (2020) · Brain · doi:10.1093/brain/awaa158 · Cited by 102
Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges
Dutta, S., Hornung, S., Taha, H. B., & Bitan, G. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02557-1 · Cited by 103
Glia in neurodegeneration: Drivers of disease or along for the ride?
Gleichman, A. J., & Carmichael, S. T. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104957 · Cited by 90
Role of microglia in spinal cord injury
Kroner, A., & Almanza, J. R. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134370 · Cited by 103
Heterogeneity of microglia and their differential roles in white matter pathology
Lee, J. C. L., Hamanaka, G., Lo, E. H., & Arai, K. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13266 · Cited by 105
Borggrewe, M., Grit, C., Den Dunnen, W. F. A., Burm, S. M., Bajramovic, J. J., Noelle, R. J., Eggen, B. J. L., & Laman, J. D. (2018) · Glia · doi:10.1002/glia.23517 · Cited by 91
Bergner, C. G., van der Meer, F., Winkler, A., Wrzos, C., Türkmen, M., Valizada, E., Fitzner, D., Hametner, S., Hartmann, C., Pfeifenbring, S., et al. (2019) · Glia · doi:10.1002/glia.23598 · Cited by 94
“…P2ry12 and the transmembrane protein 119 (Tmem119) have recently emerged as important tools for the identification of brain-resident microglia in mice and humans (Bennett et al., 2016; Butovsky et al., 2014; Mildner, Huang, Radke, Stenzel, & Priller, 2017; Zrzavy et al., 2017; Zrzavy et al., 2017).”
BackgroundSelf-citationThe Gut–CNS Axis in Multiple Sclerosis
Kadowaki, A., & Quintana, F. J. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.06.002 · Cited by 95
Böttcher, C., Fernández‐Zapata, C., Snijders, G. J. L., Schlickeiser, S., Sneeboer, M. A. M., Kunkel, D., de Witte, L. D., & Priller, J. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00992-2 · Cited by 92
Nutma, E., Gebro, E., Marzin, M. C., van der Valk, P., Matthews, P. M., Owen, D. R., & Amor, S. (2021) · Glia · doi:10.1002/glia.24052 · Cited by 95
Ostkamp, P., Deffner, M., Schulte‐Mecklenbeck, A., Wünsch, C., Lu, I., Wu, G. F., Goelz, S. E., Jager, P. L. D., Kuhlmann, T., Groß, C. C., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.adc9778 · Cited by 93
Fueling neurodegeneration: metabolic insights into microglia functions
Sadeghdoust, M., Das, A., & Kaushik, D. K. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03296-0 · Cited by 107
White matter microglia heterogeneity in the CNS
Amor, S., McNamara, N. B., Gerrits, E., Marzin, M. C., Kooistra, S. M., Miron, V. E., & Nutma, E. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02389-x · Cited by 89
The role of TAM family receptors and ligands in the nervous system: From development to pathobiology
Shafit‐Zagardo, B., Gruber, R. C., & DuBois, J. C. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.03.002 · Cited by 89
T cell interactions with microglia in immune-inflammatory processes of ischemic stroke
Zheng, Y., Ren, Z., Liu, Y., Yan, J., Chen, C., He, Y., Shi, Y., Cheng, F., Wang, Q., Li, C., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01385 · Cited by 93
Glial gene networks associated with alcohol dependence
Erickson, E. K., Blednov, Y. A., Harris, R. A., & Mayfield, R. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-47454-4 · Cited by 83
Multiplexed imaging of immune cells in staged multiple sclerosis lesions by mass cytometry
Ramaglia, V., Sheikh‐Mohamed, S., Legg, K., Park, C., Rojas, O. L., Zandee, S., Fu, F., Ornatsky, O., Swanson, E. C., Pitt, D., et al. (2019) · eLife · doi:10.7554/elife.48051 · Cited by 83
Microglial NLRP3 inflammasome activation in multiple sclerosis
(2020) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.08.007 · Cited by 83
The Transcriptional Landscape of Microglial Genes in Aging and Neurodegenerative Disease
Bonham, L. W., Sirkis, D. W., & Yokoyama, J. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01170 · Cited by 83
Duffy, S. S., Keating, B. A., Perera, C. J., Lees, J. G., Tonkin, R. S., Makker, P. G. S., Carrive, P., Butovsky, O., & Moalem‐Taylor, G. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1815-18.2019 · Cited by 86
Self-citationTargets of therapy in progressive MS
Lassmann, H. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517729455 · Cited by 83
Self-citationShen, Z., Bao, X., & Wang, R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00314 · Cited by 77
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis
Bruno, A., Dolcetti, E., Rizzo, F. R., Fresegna, D., Musella, A., Gentile, A., Vito, F. D., Caioli, S., Guadalupi, L., Bullitta, S., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00169 · Cited by 87
Maeda, J., Minamihisamatsu, T., Shimojo, M., Zhou, X., Ono, M., Matsuba, Y., Ji, B., Ishii, H., Ogawa, M., Akatsu, H., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab011 · Cited by 80
NG2 glia are required for maintaining microglia homeostatic state
Liu, Y., & Aguzzi, A. (2019) · Glia · doi:10.1002/glia.23721 · Cited by 78
Transmembrane protein 119 is neither a specific nor a reliable marker for microglia
Vankriekelsvenne, E., Chrzanowski, U., Manzhula, K., Greiner, T., Wree, A., Hawlitschka, A., Llovera, G., Zhan, J., Joost, S., Schmitz, C., et al. (2022) · Glia · doi:10.1002/glia.24164 · Cited by 84
Myeloid cell responses after spinal cord injury
David, S., Kroner, A., Greenhalgh, A. D., Zarruk, J. G., & López‐Vales, R. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.06.003 · Cited by 81
Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy
Kempthorne, L., Yoon, H., Madore, C., Smith, S., Wszolek, Z. K., Rademakers, R., Kim, J., Butovsky, O., & Dickson, D. W. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00947-0 · Cited by 77
“, P2RY12, CSF-1R) are down-regulated and inflammatory markers are up-regulated [24, 57].”
BackgroundSelf-citationSeXX Matters in Multiple Sclerosis
Gilli, F., DiSano, K. D., & Pachner, A. R. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00616 · Cited by 79
Diversity and Function of Glial Cell Types in Multiple Sclerosis
Schirmer, L., Schafer, D. P., Bartels, T., Rowitch, D. H., & Calabresi, P. A. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.01.005 · Cited by 78
Common Peripheral Immunity Mechanisms in Multiple Sclerosis and Alzheimer's Disease
Rossi, B., Santos-Lima, B., Terrabuio, E., Zenaro, E., & Constantin, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.639369 · Cited by 84
Mechanosensitive Piezo1 channel in physiology and pathophysiology of the central nervous system
Zong, B., Yu, F., Zhang, X., Pang, Y., Zhao, W., Sun, P., & Li, L. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102026 · Cited by 82
The Impact of Obesity on Microglial Function: Immune, Metabolic and Endocrine Perspectives
Alexaki, V. I. (2021) · Cells · doi:10.3390/cells10071584 · Cited by 84
Neuropathological Variability within a Spectrum of NMDAR ‐Encephalitis
Zrzavy, T., Endmayr, V., Bauer, J., Macher, S., Mossaheb, N., Schwaiger, C., Ricken, G., Winklehner, M., Glatter, S., Breu, M., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26223 · Cited by 77
Self-citationChausse, B., Lewen, A., Poschet, G., & Kann, O. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.05.052 · Cited by 74
Peruzzotti‐Jametti, L., & Pluchino, S. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.07.007 · Cited by 75
Geloso, M. C., & D’Ambrosi, N. (2021) · Cells · doi:10.3390/cells10030686 · Cited by 79
Positron emission tomography in multiple sclerosis - straight to the target
Bodini, B., Tonietto, M., Airas, L., & Stankoff, B. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00537-1 · Cited by 74
Wittekindt, M., Kaddatz, H., Joost, S., Staffeld, A., Bitar, Y., Kipp, M., & Frintrop, L. (2022) · Cells · doi:10.3390/cells11111723 · Cited by 74
Titus, H. E., Chen, Y., Podojil, J. R., Robinson, A. P., Balabanov, R. D., Popko, B., & Miller, S. D. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.599717 · Cited by 88
Simkins, T., Duncan, G. J., & BOURDETTE, D. N. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01110-5 · Cited by 79
Multiple Sclerosis: Microglia, Monocytes, and Macrophage-Mediated Demyelination
Prineas, J. W., & Parratt, J. D. E. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab083 · Cited by 76
The Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update
Sangha, A., Quon, M., Pfeffer, G., & Orton, S. M. (2023) · Nutrients · doi:10.3390/nu15132978 · Cited by 81
CNS Border-Associated Macrophages: Ontogeny and Potential Implication in Disease
Dermitzakis, I., Theotokis, P., Evangelidis, P., Delilampou, E., Evangelidis, N., Chatzisavvidou, A., Avramidou, E., & Μanthou, M. E. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45050272 · Cited by 74
Neuroinflammatory responses in experimental and human stroke lesions
Wimmer, I., Zrzavy, T., & Lassmann, H. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.07.003 · Cited by 73
Self-citationMilior, G., Morin‐Brureau, M., Chali, F., Duigou, C. L., Savary, E., Huberfeld, G., Rouach, N., Pallud, J., Capelle, L., Navarro, V., et al. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0218-19.2019 · Cited by 69
Macrophage reprogramming for therapy
Bart, V. M. T., Pickering, R. J., Taylor, P. R., & Ipseiz, N. (2020) · Immunology · doi:10.1111/imm.13300 · Cited by 73
Hamzaoui, M., Garcia, J., Boffa, G., Lazzarotto, A., Absinta, M., Ricigliano, V. A. G., Soulier, T., Tonietto, M., Gervais, P., Bissery, A., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26657 · Cited by 69
Ryan, S. K., Gonzalez, M. V., Garifallou, J. P., Bennett, F. C., Williams, K. S., Sotuyo, N. P., Mironets, E., Cook, K., Hakonarson, H. H., Anderson, S. A., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.02.010 · Cited by 65
Distinction of Microglia and Macrophages in Glioblastoma: Close Relatives, Different Tasks?
Brandenburg, S., Blank, A., Bungert, A. D., & Vajkoczy, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010194 · Cited by 65
“Ependymal‐in” Gradient of Thalamic Damage in Progressive Multiple Sclerosis
Magliozzi, R., Fadda, G., Brown, R. A., Bar‐Or, A., Howell, O. W., Hametner, S., Marastoni, D., Poli, A., Nicholas, R. S., Calabrese, M., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26448 · Cited by 68
Self-citationLopes, C., Mota, S., Deus, C., Tavares, H., & Beatriz, M. (2022) · Cells · doi:10.3390/cells11152364 · Cited by 77
Mercurio, D., Fumagalli, S., Schäfer, M., Pedragosa, J., Ngassam, L. D. C., Wilhelmi, V., Winterberg, S., Planas, A. M., Weihe, E., & Simoni, M.-G. D. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.820127 · Cited by 72
The CNS mononuclear phagocyte system in health and disease
Mundt, S., Greter, M., & Becher, B. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.005 · Cited by 68
Central nervous system demyelinating diseases: glial cells at the hub of pathology
Costa, V. G. C., Espírito‐Santo, S., Alves‐Leon, S. V., & Gomes, F. C. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1135540 · Cited by 73
Snijders, G. J. L., Sneeboer, M. A. M., Fernández-Andreu, A., Udine, E., (NBB-Psy), P. D. P. O. T. N. B. B., Boks, M. P., Ormel, P. R., van Berlekom, A. B., van Mierlo, H. C., Böttcher, C., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00896-z · Cited by 66
Sex Differences in Neurodegeneration: The Role of the Immune System in Humans
Lopez-Lee, C., Kodama, L., & Gan, L. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.01.002 · Cited by 69
The Ins and Outs of Central Nervous System Inflammation—Lessons Learned from Multiple Sclerosis
Ramaglia, V., Rojas, O. L., Naouar, I., & Gommerman, J. L. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-093019-124155 · Cited by 72
Retinal and brain microglia in multiple sclerosis and neurodegeneration
Choi, S., Guo, L., & Cordeiro, M. F. (2021) · Cells · doi:10.3390/cells10061507 · Cited by 63
Towards PET imaging of the dynamic phenotypes of microglia
Beaino, W., Janssen, B., Vugts, D. J., de Vries, H. E., & Windhorst, A. D. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13649 · Cited by 63
Immune mechanisms and shared immune targets in neurodegenerative diseases
Weiner, H. L. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01046-7 · Cited by 72
Self-citationChronic active lesions in multiple sclerosis: classification, terminology, and clinical significance
Dal‐Bianco, A., Oh, J., Sati, P., & Absinta, M. (2024) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864241306684 · Cited by 61
Sabogal-Guáqueta, A. M., Marmolejo-Garza, A., de Pádua, V. P., Eggen, B. J. L., Boddeke, E., & Dolga, A. M. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101805 · Cited by 65
GPCRomics of homeostatic and disease-associated human microglia
Hsiao, C.-C., Sankowski, R., Prinz, M., Smolders, J., Huitinga, I., & Hamann, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.674189 · Cited by 59
Recent advances in understanding multiple sclerosis
Stys, P. K., & Tsutsui, S. (2019) · F1000Research · doi:10.12688/f1000research.20906.1 · Cited by 60
Promises and Limitations of Neural Stem Cell Therapies for Progressive Multiple Sclerosis
Pluchino, S., Smith, J. A., & Peruzzotti‐Jametti, L. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.04.005 · Cited by 59
Poirion, E., Tonietto, M., Lejeune, F., Ricigliano, V., de la Motte, M. B., Benoit, C., Bera, G., Kuhnast, B., Bottlaender, M., Bodini, B., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011700 · Cited by 54
Sikkema, A. H., Stoffels, J. M. J., Wang, P., Basedow, F. J., Bulsink, R., Bajramovic, J. J., & Baron, W. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1238-x · Cited by 60
Wei, W., Lattau, S. S. J., Xin, W., Pan, Y., Tatenhorst, L., Zhang, L., Graf, I., Kuang, Y., Zheng, X., Hao, Z., et al. (2024) · Advanced Science · doi:10.1002/advs.202306863 · Cited by 59
Abdi, M., Pasbakhsh, P., Shabani, M., Nekoonam, S., Sadeghi, A., Fathi, F., Abouzaripour, M., Mohamed, W. M. Y., Zibara, K., Kashani, I. R., et al. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00417-y · Cited by 57
Seicol, B. J., Lin, S., & Xie, R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.846804 · Cited by 58
The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data
Vakrakou, A. G., Alexaki, A., Brinia, M.-E., Anagnostouli, M. C., Stefanis, L., & Stathopoulos, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158077 · Cited by 65
How does neurovascular unit dysfunction contribute to multiple sclerosis?
Cashion, J. M., Young, K. M., & Sutherland, B. A. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106028 · Cited by 58
STAT6 mediates the effect of ethanol on neuroinflammatory response in TBI
Heuvel, F. O., Holl, S., Chandrasekar, A., Li, Z., Wang, Y., Rehman, R., Förstner, P., Sinske, D., Palmer, A., Wiesner, D., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.06.019 · Cited by 56
Microglia as therapeutic target in central nervous system disorders
Fatoba, O., Itokazu, T., & Yamashita, T. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.07.004 · Cited by 57
Maurya, S. K., Bhattacharya, N., Mishra, S., Bhattacharya, A., Banerjee, P., Senapati, S., & Mishra, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.654489 · Cited by 59
Microglial Extracellular Vesicles as Vehicles for Neurodegeneration Spreading
Aires, I. D., Ribeiro‐Rodrigues, T., Boia, R., Ferreira-Rodrigues, M., Girão, H., Ambrósio, A. F., & Santiago, A. R. (2021) · Biomolecules · doi:10.3390/biom11060770 · Cited by 57
Effect of puberty on the immune system: Relevance to multiple sclerosis
Ucciferri, C. C., & Dunn, S. E. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.1059083 · Cited by 58
Novel Microglia-based Therapeutic Approaches to Neurodegenerative Disorders
Zhang, L., Wang, Y., Liu, T., Mao, Y. Q., & Peng, B. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-022-01013-6 · Cited by 59
Microglial innate memory and epigenetic reprogramming in neurological disorders
Martins-Ferreira, R., Leal, B., Costa, P., & Ballestar, E. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101971 · Cited by 55
Hametner, S., Bianco, A. D., Trattnig, S., & Lassmann, H. (2018) · Brain Pathology · doi:10.1111/bpa.12643 · Cited by 59
Self-citationDynamic response of microglia/macrophage polarization following demyelination in mice
Chu, T., Zhang, Y. P., Tian, Z., Ye, C., Zhu, M., Shields, L. B. E., Kong, M., Barnes, G. N., Shields, C. B., & Cai, J. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1586-1 · Cited by 55
Zhang, W., Zhang, X., Zhang, Y., Qu, C., Zhou, X., & Zhang, S. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09887-6 · Cited by 57
Sun, Y., Wei, K., Liao, X., Wang, J., Gao, L., & Pang, B. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5580 · Cited by 63
Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model
Wilmes, A. T., Reinehr, S., Kühn, S., Pedreiturria, X., Petrikowski, L., Faissner, S., Ayzenberg, I., Stute, G., Gold, R., Dick, H. B., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1208-3 · Cited by 54
Pryce, G., & Baker, D. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.07.030 · Cited by 57
Microglia in multiple sclerosis - pathogenesis and imaging
Airas, L., & Yong, V. W. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001045 · Cited by 52
Dysregulated copper transport in multiple sclerosis may cause demyelination via astrocytes
Colombo, E., Triolo, D., Bassani, C., Bedogni, F., Di Dario, M., Dina, G., Fredrickx, E., Fermo, I., Martinelli, V., Newcombe, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025804118 · Cited by 52
Niu, T., Fang, J., Shi, X., Zhao, M., Xing, X., Wang, Y., Zhu, S., & Liu, K. (2021) · Diabetes · doi:10.2337/db20-0839 · Cited by 51
Sidoryk‐Wȩgrzynowicz, M., & Strużyńska, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168404 · Cited by 51
Brain region- and sex-specific transcriptional profiles of microglia
Barko, K., Shelton, M. A., Xue, X., Afriyie-Agyemang, Y., Puig, S., Freyberg, Z., Tseng, G. C., Logan, R. W., & Seney, M. L. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.945548 · Cited by 56
Vanderwall, A. G., Noor, S., Sun, M. S., Sanchez, J. E., Yang, X. O., Jantzie, L. L., Mellios, N., & Milligan, E. D. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.11.004 · Cited by 51
CHIT1 at Diagnosis Reflects Long‐Term Multiple Sclerosis Disease Activity
Oldoni, E., Smets, I., Mallants, K., Vandebergh, M., Van Horebeek, L., Poesen, K., Dupont, P., Dubois, B., & Goris, A. (2020) · Annals of Neurology · doi:10.1002/ana.25691 · Cited by 50
Berdowski, W. M., van der Linde, H. C., Breur, M., Oosterhof, N., Beerepoot, S., Sanderson, L. E., Wijnands, L. I., de Jong, P., Tsai-Meu-Chong, E., de Valk, W. G., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02440-5 · Cited by 52
Lassmann, H. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000685 · Cited by 50
Self-citation
Metadata
- Authors
- Zrzavy, T., Hametner, S., Wimmer, I., Butovsky, O., Weiner, H. L., & Lassmann, H.
- Affiliations
- Medical University of Vienna (AT)
- Brigham and Women's Hospital (US)
- Corresponding author
- Lassmann, Hans
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-05-24
- Volume
- 140
- Issue
- 7
- Pages
- 1900-1913
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC6057548
- OpenAlex
- W2620266814
- Cited by
- 684
- References
- 68
- Citations by year
- 2026: 62 · 2025: 65 · 2024: 78 · 2023: 87 · 2022: 92 · 2021: 116 · 2020: 71 · 2019: 60 · 2018: 43 · 2017: 10
- FWCI
- 39.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- NIH (R01NS088137)
- National Multiple Sclerosis Society (5092A1)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- multiple sclerosis, microglia, macrophages, homeostatic microglia, microglial activation, P2Y12 receptor, TMEM119, normal-appearing white matter, demyelination, neurodegeneration, lesion activity, disease duration, pro-inflammatory phenotype, anti-inflammatory phenotype, phagocytosis, oxidative damage, antigen presentation, T cell costimulation, microglial origin
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, Demyelinating Diseases, Female, Homeostasis, Humans, Macrophage Activation, Male, Membrane Proteins, Middle Aged, Multiple Sclerosis, Nerve Degeneration, Case-Control Studies, Microglia, Receptors, Purinergic P2Y12, White Matter
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
